
| 5 min read
Clinical trial updates, regulatory approvals, and more led the news this week.
| 4 min read
BCG vaccination reduced tau pathology and neuroinflammation in mice, prompting researchers to investigate whether trained immunity could inform future treatments for Alzheimer’s disease.
| 3 min read
Bacterial genomes recovered from discarded DNA sequencing data could help researchers investigate whether microbes contribute to aggressive prostate cancer.
| 4 min read
A machine learning-based screen identified SRSF1 as a potential target for reversing several hallmarks of aging without erasing cell identity, with further testing revealing benefits in aged mice.News
Cancer Research News
John Yu built Kairos Pharma on a simple bet: Cancer drugs don't fail, tumors just learn to outrun them.
Imagene AI's quantitative pathology and CellCarta's CDx infrastructure offer biopharma sponsors one path from AI biomarker assay to regulatory submission
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Explore how direct cell lysis can reduce sample preparation steps and support efficient gene expression analysis by RT-qPCR.
Expert insights on the ideas and innovations reshaping the field.





















